Trailing-twelve-month (TTM) revenue is $473.90 Million with a year-over-year growth of +8.47%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $74,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $146,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $76,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $176,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $473,900,000 |
Current P/S: $2,874,881,138 market capitalization ÷ $473,900,000 TTM revenue = 6.07x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T17:10:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $176.10M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T17:11:04.511Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | N/A | N/A | N/A | $269M | $350M | $346M |
| Separative Work Units | $152M | $163M | $196M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| BELGIUM | $36M | $37M | $38M | $100,000 | N/A | N/A |
| Foreign | N/A | N/A | N/A |
$473.90M
$473.90 Million
+8.47%
vs. $436.89M a year ago (TTM)
+14.15%
5 Year compound annual growth rate
1 Year
+8.47%
3 Year
+13.43%
5 Year
+14.15%
10 Year
+3.36%
15 Year
(9.35%)
20 Year
(6.60%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $448.70M | +$6.70M | +1.52% |
| 2024 | $442.00M | +$121.80M | +38.04% |
| 2023 | $320.20M | +$26.40M | +8.99% |
| 2022 | $293.80M | ($4.50M) | (1.51%) |
| 2021 | $298.30M | +$51.10M | +20.67% |
| 2020 |
TTM Growth
+8.47%
3-Year CAGR
+13.43%
5-Year CAGR
+14.15%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T17:11:04.511Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $208M |
| $247M |
| $299M |
| Service | $57M | $112M | $58M | N/A | N/A | N/A |
|---|
| Uranium | $39M | $23M | $39M | $61M | $103M | $48M |
|---|
| N/A |
| N/A |
| $113M |
| JAPAN | $23M | $35M | $62M | $24M | $117M | $103M |
|---|
| NETHERLANDS | N/A | N/A | N/A | N/A | $42M | N/A |
|---|
| Other | $16M | $7M | $40M | $15M | $29M | N/A |
|---|
| Other Foreign | N/A | N/A | N/A | N/A | N/A | $11M |
|---|
| UNITED STATES | $172M | $221M | $154M | $282M | $253M | $335M |
|---|
| $247.20M |
| +$37.50M |
| +17.88% |
| 2019 | $209.70M | +$16.70M | +8.65% |
| 2018 | $193.00M | ($25.40M) | (11.63%) |
| 2017 | $218.40M | ($92.90M) | (29.84%) |
| 2016 | $311.30M | ($106.90M) | (25.56%) |
